Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income	$ (150,407)	$ (443,693)	$ 493,303
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	130,178	270,753	248,329
Long-lived Asset and Goodwill, Impairments	436,908	436,908	152,712
Lower of cost or market inventory valuation adjustment	(269,904)	290,560	(184,545)
Earnings of equity method investments, inclusive of distributions		(1,298)	0
Loss on early extinguishment of debt	0	25,915	0
Gain on sales-type lease	(33,834)	(33,834)	0
(Gain) loss on sale of assets		(357)	73
Deferred income taxes	34,696	(116,030)	58,193
Equity-based compensation expense		14,289	21,562
Change in fair value - derivative instruments		(9,377)	31,454
(Increase) decrease in current assets:
Accounts receivable		281,011	(72,300)
Inventories		(764)	(6,708)
Income taxes receivable		(72,382)	(26,835)
Prepayments and other		9,704	14,020
Increase (decrease) in current liabilities:
Accounts payable		(314,892)	292,893
Income taxes payable		(9,268)	7,826
Accrued liabilities		3,340	38,003
Turnaround expenditures		(49,248)	(110,273)
Other, net		27,965	11,843
Net cash provided by (used for) operating activities		309,302	969,550
Cash flows from investing activities:
Additions to properties, plants and equipment		(98,996)	(102,717)
Purchase of business, net of cash acquired		0	(662,665)
Investment in equity company - HEP		(2,400)	0
Other, net		470	825
Net Cash Provided by (Used in) Investing Activities		(131,666)	(782,309)
Cash flows from financing activities:
Borrowings under credit agreement		168,000	175,000
Repayments under credit agreement		(138,500)	(156,500)
Proceeds from issuance of senior notes - HEP		500,000	0
Proceeds from issuance of common units - HEP		(522,500)	0
Purchase of treasury stock		(1,243)	(266,996)
Dividends		(114,430)	(113,508)
Contribution from Joint Venture Partner		13,263	0
Proceeds from disgorgement of stockholder short-swing profits	603
Shares withheld for tax withholding obligations		(843)	(783)
Deferred financing costs		(8,714)	0
Proceeds from (Payments for) Other Financing Activities		456	(374)
Net cash used for financing activities		(155,519)	(429,864)
Effect of exchange rate on cash flow		(4,770)	2,515
Cash and cash equivalents:
Increase (decrease) for the period		17,347	(240,108)
Beginning of period		885,162	1,154,752
End of period	902,509	902,509	914,644
Cash paid during the period for:
Interest		(64,003)	(67,620)
Income taxes, net		(4,738)	(138,587)
HEP
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	24,008	47,986
Long-lived Asset and Goodwill, Impairments			0
Lower of cost or market inventory valuation adjustment	$ 0	0	0
Cash flows from investing activities:
Additions to properties, plants and equipment		(30,740)	(17,752)
Cash flows from financing activities:
Payments to Noncontrolling Interests		$ (51,008)	$ (66,703)